Tuberculosis and Respiratory Diseases

  • 제79권2호
  • /
  • Pages.70-73
  • /
  • 2016
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

The 2009 H1N1 Pandemic Influenza in Korea

  • Kim, Jae Yeol (Department of Internal Medicine, Chung-Ang University College of Medicine)
  • 투고 : 2015.12.17
  • 심사 : 2016.01.06
  • 발행 : 2016.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

In late March of 2009, an outbreak of influenza in Mexico, was eventually identified as H1N1 influenza A. In June 2009, the World Health Organization raised a pandemic alert to the highest level. More than 214 countries have reported confirmed cases of pandemic H1N1 influenza A. In Korea, the first case of pandemic influenza A/H1N1 infection was reported on May 2, 2009. Between May 2009 and August 2010, 750,000 cases of pandemic influenza A/H1N1 were confirmed by laboratory test. The H1N1-related death toll was estimated to reach 252 individuals. Almost one billion cases of influenza occurs globally every year, resulting in 300,000 to 500,000 deaths. Influenza vaccination induces virus-neutralizing antibodies, mainly against hemagglutinin, which provide protection from invading virus. New quadrivalent inactivated influenza vaccine generates similar immune responses against the three influenza strains contained in two types of trivalent vaccines and superior responses against the additional B strain.

키워드

참고문헌

  1. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 2002;76:105-15. https://doi.org/10.1353/bhm.2002.0022
  2. Morens DM, Fauci AS. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 2007;195:1018-28. https://doi.org/10.1086/511989
  3. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG. Initial genetic characterization of the 1918 “Spanish” influenza virus. Science 1997;275:1793-6. https://doi.org/10.1126/science.275.5307.1793
  4. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, Swayne DE, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005;310:77-80. https://doi.org/10.1126/science.1119392
  5. Xu R, McBride R, Paulson JC, Basler CF, Wilson IA. Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic. J Virol 2010;84:1715-21. https://doi.org/10.1128/JVI.02162-09
  6. Masurel N, Marine WM. Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man. Am J Epidemiol 1973;97:44-9. https://doi.org/10.1093/oxfordjournals.aje.a121483
  7. World Health Organization. Pandemic (H1N1) 2009: update 112 [Internet]. Geneva: World Health Organization; 2010 [cited 2010 Oct 4]. Available from: http://www.who.int/csr/don/2010_08_06/en/index.html.
  8. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-15. https://doi.org/10.1056/NEJMoa0903810
  9. Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 2011;52 Suppl 1:S75-82. https://doi.org/10.1093/cid/ciq012
  10. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012;12:687-95. https://doi.org/10.1016/S1473-3099(12)70121-4
  11. Simonsen L, Spreeuwenberg P, Lustig R, Taylor RJ, Fleming DM, Kroneman M, et al. Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Med 2013;10:e1001558. https://doi.org/10.1371/journal.pmed.1001558
  12. Fowlkes AL, Arguin P, Biggerstaff MS, Gindler J, Blau D, Jain S, et al. Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009. Clin Infect Dis 2011;52 Suppl 1:S60-8. https://doi.org/10.1093/cid/ciq022
  13. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009;302:1896-902. https://doi.org/10.1001/jama.2009.1583
  14. Suh M, Kang DR, Lee DH, Choi YJ, Tchoe B, Nam CM, et al. Socioeconomic burden of influenza in the Republic of Korea, 2007-2010. PLoS One 2013;8:e84121. https://doi.org/10.1371/journal.pone.0084121
  15. Choi WI, Yim JJ, Park J, Kim SC, Na MJ, Lee WY, et al. Clinical characteristics and outcomes of H1N1-associated pneumonia among adults in South Korea. Int J Tuberc Lung Dis 2011; 15:270-5.
  16. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44. https://doi.org/10.1056/NEJMoa0906695
  17. ANZIC Influenza Investigators, Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-34. https://doi.org/10.1056/NEJMoa0908481
  18. Lee MC, Kim HY, Kong SG, Kim YM, Park SE, Im YT, et al. Clinical characteristics of pandemic influenza A (H1N1) 2009 pediatric infection in Busan and Gyeongsangnam-do: one institution. Tuberc Respir Dis 2012;72:493-500. https://doi.org/10.4046/trd.2012.72.6.493
  19. Kim YW, Yoon SJ, Oh IH. The economic burden of the 2009 pandemic H1N1 influenza in Korea. Scand J Infect Dis 2013; 45:390-6. https://doi.org/10.3109/00365548.2012.749423
  20. Centers for Disease Control and Prevention. The flu season [Internet]. Atlanta: Centers for Disease Control and Prevention; 2014 [cited 2015 Dec 11]. Available from: http://www.cdc.gov/flu/about/season/flu-season.htm.
  21. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289: 179-86. https://doi.org/10.1001/jama.289.2.179
  22. Webster RG, Wright SM, Castrucci MR, Bean WJ, Kawaoka Y. Influenza: a model of an emerging virus disease. Intervirology 1993;35:16-25. https://doi.org/10.1159/000150292
  23. Webster RG, Kendal AP, Gerhard W. Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations. Virology 1979;96:258-64. https://doi.org/10.1016/0042-6822(79)90189-2
  24. Caini S, Huang QS, Ciblak MA, Kusznierz G, Owen R, Wangchuk S, et al. Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza Other Respir Viruses 2015;9 Suppl 1:3-12. https://doi.org/10.1111/irv.12319
  25. Uyeki TM. Preventing and controlling influenza with available interventions. N Engl J Med 2014;370:789-91. https://doi.org/10.1056/NEJMp1400034
  26. Heikkinen T, Ikonen N, Ziegler T. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012. Clin Infect Dis 2014;59:1519-24. https://doi.org/10.1093/cid/ciu664
  27. Domachowske JB, Pankow-Culot H, Bautista M, Feng Y, Claeys C, Peeters M, et al. A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years. J Infect Dis 2013;207:1878-87. https://doi.org/10.1093/infdis/jit091
  28. Tinoco JC, Pavia-Ruz N, Cruz-Valdez A, Aranza Doniz C, Chandrasekaran V, Dewe W, et al. Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged $\geq$18 years: a phase III, randomized trial. Vaccine 2014;32:1480-7. https://doi.org/10.1016/j.vaccine.2014.01.022
  29. Centers for Disease Control and Prevention. Vaccination: who should do it, who should not and who should take precautions [Internet]. Atlanta: Centers for Disease Control and Prevention; 2015 [cited 2015 Dec 11]. Available from: http://www.cdc.gov/flu/protect/whoshouldvax.htm.

피인용 문헌

  1. Protective Effect of Panax notoginseng Root Water Extract against Influenza A Virus Infection by Enhancing Antiviral Interferon-Mediated Immune Responses and Natural Killer Cell Activity vol.8, pp.None, 2016, https://doi.org/10.3389/fimmu.2017.01542
  2. 보건계열 대학생의 중동호흡기증후군에 대한 지식, 태도 및 예방행위 실천도와의 관계 vol.17, pp.4, 2016, https://doi.org/10.17135/jdhs.2017.17.4.341
  3. Estimating Mortality Incidence for the 2009 H1N1 Pandemic: A Metaanalysis from 21 Countries in the WHO Eastern Mediterranean Region vol.14, pp.4, 2016, https://doi.org/10.2174/1573398x15666190112100735
  4. Biocalyptic imaginations in Japanese and Korean films: undead nation-states inI Am a HeroandTrain to Busan vol.20, pp.3, 2019, https://doi.org/10.1080/14649373.2019.1649015
  5. When the illiberal and the neoliberal meet around infectious diseases: an examination of the MERS response in South Korea vol.8, pp.1, 2016, https://doi.org/10.1080/21622671.2019.1700825
  6. 응급구조(학)과 학생의 메르스에 관한 지식, 태도 및 예방행위와의 관계 vol.21, pp.5, 2016, https://doi.org/10.5762/kais.2020.21.5.401
  7. Impact of travel ban implementation on COVID-19 spread in Singapore, Taiwan, Hong Kong and South Korea during the early phase of the pandemic: a comparative study vol.21, pp.1, 2016, https://doi.org/10.1186/s12879-021-06449-1